본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
GRPR Drives Metastasis via CRABP2 and FNDC4 Pathways in Lung Adenocarcinoma Kim Youn Jae
(Targeted Therapy Branch)

Kim Dong-Gun
(Targeted Therapy Branch)
. GRPR Drives Metastasis via CRABP2 and FNDC4 Pathways in Lung Adenocarcinoma. CELLS. 2024-12-23; 2024; 13(24):2128~. IF 5.1 (2023)
Blood-based biomarkers for identifying disease activity in AQP4-IgG-positive neuromyelitis optica spectrum disorder Kim Ho Jin
(Department of Neurology)

Kim Su-Hyun
(Department of Neurology)
. Blood-based biomarkers for identifying disease activity in AQP4-IgG-positive neuromyelitis optica spectrum disorder. JAMA NEUROLOGY. 2024-12-23; 2024; :~. IF 20.9 (2023)
Validity and reliability of the integrated palliative care outcome scale (IPOS) in Korea: a multicenter study of terminally ill cancer patients Chang Yoon Jung
(National Cancer Surviorship Center)

Park So Jung
(Department of Hospice Palliative Service)
. Validity and reliability of the integrated palliative care outcome scale (IPOS) in Korea: a multicenter study of terminally ill cancer patients. BMC PALLIATIVE CARE. 2024-12-23; 2024; 23:298~. IF 2.5 (2023)
Association between chronic ambient heavy metal exposure and mental health in Korean adult patients with asthma and the general population Kim Hyun Jin
(Data Link & Operation Team)

Kim Byung Mi
(Division of Cancer Prevention)
. Association between chronic ambient heavy metal exposure and mental health in Korean adult patients with asthma and the general population. CHEMOSPHERE. 2024-12-21; 2024; 370:144002~. IF 8.1 (2023)
Neurofilament light chain as a discriminator of disease activity status in MOG antibody-associated disease Kim Ho Jin
(Department of Neurology)

Kim Su-Hyun
(Department of Neurology)
. Neurofilament light chain as a discriminator of disease activity status in MOG antibody-associated disease. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2024-12-20; 2024; 12(1):~. IF 8.3 (2023)
Machine learning algorithms that predict the risk of prostate cancer based on metabolic syndrome and sociodemographic characteristics: a prospective cohort study Kim Jeong seon
(Department of Cancer AI and Digital Health)


(Department of Cancer Control and Population Health)
. Machine learning algorithms that predict the risk of prostate cancer based on metabolic syndrome and sociodemographic characteristics: a prospective cohort study. BMC PUBLIC HEALTH. 2024-12-20; 2024; 24:3549~. IF 3.5 (2023)
Role and Effectiveness of Hypofractionated Proton Beam Therapy and Combinations with Systemic Chemotherapy in Inoperable Extrahepatic Cholangiocarcinoma Kim, Tae Hyun
(Radiological Science？Branch)

Lee Sung Uk
(Radiological Science？Branch)
. Role and Effectiveness of Hypofractionated Proton Beam Therapy and Combinations with Systemic Chemotherapy in Inoperable Extrahepatic Cholangiocarcinoma. CANCER RESEARCH AND TREATMENT. 2024-12-17; 2024; :~. IF 4.1 (2023)
A Machine Learning Risk Prediction Model for Gastric Cancer with SHapley Additive exPlanations Oh Hyun Jin
(Branch of Gastroenterology)


()
. A Machine Learning Risk Prediction Model for Gastric Cancer with SHapley Additive exPlanations. CANCER RESEARCH AND TREATMENT. 2024-12-16; 2024; :~. IF 4.1 (2023)
ATR inhibition promotes synergistic antitumor effect in platinum-resistant pancreatic cancer Kim Yun-Hee
(Cancer Molecular Imaging Branch)

Chun Jung Won
(Interventional Medicine Branch)
. ATR inhibition promotes synergistic antitumor effect in platinum-resistant pancreatic cancer. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2024-12-15; 2024; 1871(3):167625~. IF 4.2 (2023)
Translationally controlled tumor protein enhances angiogenesis in ovarian tumors by activating vascular endothelial growth factor receptor 2 signaling Rho Seung Bae
(Cancer Metastasis Branch)

Rho Seung Bae
(Cancer Metastasis Branch)
. Translationally controlled tumor protein enhances angiogenesis in ovarian tumors by activating vascular endothelial growth factor receptor 2 signaling. BIOMOLECULES & THERAPEUTICS. 2024-12-12; 2024; 33(1):193~202. IF 3 (2023)
First page Prev paging 1 2 3 4 5 6 7 8 9 10 next paging last page